# Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.

> PubMed lists PMID 34623544 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-10-08 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-34623544-elamipretide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-07-28
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-34623544-elamipretide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-34623544-elamipretide-v1.json
- Content SHA-256: `150aceb643e992e01d9dfbfb3ab42d7dd15625d82aad00133ed2b4505f8e40d0`

## Claims and source pins

### Headline

Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid. ([`pubmed-observation-pmid-34623544-2025-07-28-067e0526282b`](#source-pubmed-observation-pmid-34623544-2025-07-28-067e0526282b))

### Summary

PubMed lists PMID 34623544 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-10-08 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34623544-2025-07-28-067e0526282b`](#source-pubmed-observation-pmid-34623544-2025-07-28-067e0526282b))

### Paragraph 1

PubMed lists PMID 34623544 in Heart failure reviews as Journal Article, Review, Research Support, Non-U.S. Gov't, with publication-date metadata of 2021-10-08 (day precision). PeptideScanner associated the retained record with the identity slug elamipretide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-34623544-2025-07-28-067e0526282b`](#source-pubmed-observation-pmid-34623544-2025-07-28-067e0526282b))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-34623544-2025-07-28-067e0526282b`](#source-pubmed-observation-pmid-34623544-2025-07-28-067e0526282b))

## Sources

<a id="source-pubmed-observation-pmid-34623544-2025-07-28-067e0526282b"></a>
- **Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid. · retained source version 1:2025-07-28:current:067e0526282b47ad3def0faf0a9a390d8b25739774fa6b0553cfaac868cc63e5** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/34623544/) (`pubmed-observation-pmid-34623544-2025-07-28-067e0526282b`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-34623544-elamipretide-v1.json SHA-256: 150aceb643e992e01d9dfbfb3ab42d7dd15625d82aad00133ed2b4505f8e40d0.